Loprox and Dalmane drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Loprox (ciclopirox) and Dalmane (flurazepam hydrochloride). Common drug interactions include anaemia among males.

The phase IV clinical study analyzes what interactions people have when they take Loprox and Dalmane. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Loprox?

Loprox has active ingredients of ciclopirox. eHealthMe is studying from 618 Loprox users. Check the latest studies of Loprox.

What is Dalmane?

Dalmane has active ingredients of flurazepam hydrochloride. It is often used in insomnia. eHealthMe is studying from 1,269 Dalmane users. Check the latest studies of Dalmane.



On Apr, 14, 2026

13 people who take Loprox and Dalmane together, and have interactions are studied.

Loprox and Dalmane drug interactions.

What are the common drug interactions of Loprox and Dalmane, by gender? *:

female:

n/a

male:

  1. Anaemia (lack of blood)
  2. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  3. Infection
  4. Injury
  5. Osteitis (a general term for inflammation of bone)
  6. Pain
  7. Skin lesion
  8. Swelling
  9. Tooth abscess (pus formation in tooth)
  10. Cellulitis (infection under the skin)

What are the common drug interactions of Loprox and Dalmane, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Anaemia (lack of blood)
  2. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  3. Infection
  4. Injury
  5. Osteitis (a general term for inflammation of bone)
  6. Pain
  7. Skin lesion
  8. Swelling
  9. Tooth abscess (pus formation in tooth)
  10. Cellulitis (infection under the skin)

What are the existing conditions these people have? *

  1. Multiple Myeloma (cancer of the plasma cells): 1 person, 7.69%
  2. Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Loprox and Dalmane?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Loprox and Dalmane:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Loprox:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Dalmane:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Loprox and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Dalmane and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on ciclopirox and flurazepam hydrochloride (the active ingredients of Loprox and Dalmane, respectively), and Loprox and Dalmane (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: